International ALS gene search begins

May 16, 2006

U.S. scientists are leading the first international gene search for typical ALS -- amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Although it's the more common form of the disease, sporadic ALS -- affecting about 90 percent of those living with the fatal neurodegenerative illness -- has been the one less studied, simply because, unlike familial ALS, no genes have been determined involved.

This week, however Dr. Bryan Traynor and John Hardy of the Packard Center for ALS Research at Johns Hopkins University are beginning the first in-depth screening for genes that underlie the "spontaneous" illness, which, as all ALS, destroys the motor neurons that enable movement, including breathing. Half of the study focuses on Italian populations.

"In the forest of exciting research that's going on in ALS," said Packard Director Jeffrey Rothstein, "this is a tall tree. We've been waiting some time for this one."

Traynor said the work will clarify the role of genes in sporadic ALS. He added: "We don't know, for example, if (sporadic) ALS is triggered by a handful of interacting genes or genes plus environment or environment alone. The study aims to clarify that."

Copyright 2006 by United Press International

Explore further: Female triathletes at risk for pelvic floor disorders and other complications

add to favorites email to friend print save as pdf

Related Stories

Mechanical forces in development

Dec 13, 2013

(Phys.org) —Early embryonic development is a marvel of mechanics. Its signature step is the production of three tissue layers—mesoderm, ectoderm, and endoderm—through a topological maneuver known as ...

Clinton warns of bioweapon threat from gene tech

Dec 07, 2011

(AP) -- New gene assembly technology that offers great benefits for scientific research could also be used by terrorists to create biological weapons, U.S. Secretary of State Hillary Rodham Clinton warned ...

Scientists reveal key barrier to reprogramming human zygotes

Oct 06, 2011

(Medical Xpress) -- New research from Howard Hughes Medical Institute (HHMI) scientists pinpoints a biological barrier that has thus far slowed progress in creating disease-specific stem cell lines using a technique known ...

Recommended for you

New treatment fights common infant virus

30 minutes ago

Researchers at Le Bonheur Children's Hospital and the University of Tennessee Health Science Center announced results of a clinical trial of a new drug shown to safely reduce the viral load and clinical illness of healthy ...

User comments : 0